Taiwan Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Taiwan Pharmaceuticals and Healthcare Report Q3 2013 May 22nd 2013, 00:00 BMI View: Taiwan will continue to represent a modestly attractive proposition for drug manufactures. Our view is based on factors such as the maturity of its pharmaceutical market, government encouragement of generic medicines and authorities desire to reduce unnecessary use of medicines. For example, the Bureau of National Health Insurance (BNHI) in Taiwan is cracking down on prescription drugs waste by tightening its oversight of prescription drug distribution. Therefore, we envisage that main drivers of the Taiwanese pharmaceutical market development will be volume- based, thus not necessarily translating into strong value gains, especially given the pending changes to reimbursement. Headline … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=97354. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/taiwan-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions